DRKS00022785进行中（未招募）不适用
Beating Heart Mitral Valve REPair With the HARPOON™ System: ReaL World Outcomes From a multICenter observATional European Registry - REPLICATE
Harpoon Medical, an indirect wholly-owned subsidiary of Edwards Lifesciences Corporation, Edwards Lifesciences0 个研究点目标入组 26 人开始时间: 2020年10月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Subjects who are clinically suitable for treatment with the HARPOON™ System, as per the Instructions for Use (IFU), will be evaluated for inclusion in the registry.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Stentless mitral valve replacement using autologous pericardium studyMitral regurgitationJPRN-UMIN000012659Sakakibara Heart Institute25
已完成
不适用
Stentless mitral valve replacement using autologous pericardium studyMitral valve diseaseJPRN-UMIN000021445Keio University School of Medicine30
暂停
不适用
Stentless mitral valve replacement using autologous pericardium studyMitral regurgitationJPRN-jRCT1032180087Shimokawa Tomoki25
已完成
不适用
Tiara* Transcatheter Mitral Valve Replacement Studysevere mitral regurgitation10046973NL-OMON49193eovasc Medical Inc.30
已完成
不适用
Mitral valve surgery using stentress bioprosthesis made from autologous pericardiumMitral insufficiencyJPRN-UMIN000017201CV suregry5